Geographical mapping and seroprevalence of Burkholderia pseudomallei amongst livestock species in Lao People's Democratic Republic.
Zheng S. et al, (2025), PLoS neglected tropical diseases, 19
Sustainable antimicrobial resistance surveillance: time for a global funding mechanism
Painter C. et al, (2025), The Lancet Infectious Diseases, 25, e99 - e103
Insights of SEDRIC, the Surveillance and Epidemiology of Drug-Resistant Infections Consortium
Feasey N. et al, (2025), Wellcome Open Research, 10, 5 - 5
Insights of SEDRIC, the Surveillance and Epidemiology of Drug-Resistant Infections Consortium.
Feasey N. et al, (2025), Wellcome open research, 10
Predicting mortality in febrile adults: comparative performance of the MEWS, qSOFA, and UVA scores using prospectively collected data among patients in four health-care sites in sub-Saharan Africa and South-Eastern Asia
Lal S. et al, (2024), eClinicalMedicine, 77, 102856 - 102856
WHO global research priorities for antimicrobial resistance in human health
Bertagnolio S. et al, (2024), The Lancet Microbe, 5, 100902 - 100902
AmpC β-lactamases detected in Southeast Asian Escherichia coli and Klebsiella pneumoniae
Roberts T. et al, (2024), JAC-Antimicrobial Resistance, 6
Antimicrobial susceptibility profiles of invasive bacterial infections among children from low- and middle-income countries in the Western Pacific Region (WPRO) – a systematic review and meta-analysis
Moore N. et al, (2024), The Lancet Regional Health - Western Pacific, 51, 101177 - 101177
Understanding hospital antimicrobial prescribing decisions and determinants of uptake of new local antimicrobial prescribing guidelines in Laos
Chansamouth V. et al, (2024), Wellcome Open Research, 9, 183 - 183
Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050
Naghavi M. et al, (2024), The Lancet, 404, 1199 - 1226
Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)
Wongnak P. et al, (2024), The Lancet Infectious Diseases, 24, 953 - 963
Case Report: Herpes simplex virus type 2 (HSV-2) meningo-encephalitis associated with traumatic brain injury – a case report from Lao PDR
Vannachone S. et al, (2024), Wellcome Open Research, 9, 489 - 489
Dry Swabs and Dried Saliva as Alternative Samples for SARS-CoV-2 Detection in Remote Areas in Lao PDR.
Sibounheuang B. et al, (2024), Open forum infectious diseases, 11
Optimising Clinical Epidemiology in Disease Outbreaks: Analysis of ISARIC-WHO COVID-19 Case Report Form Utilisation.
Merson L. et al, (2024), Epidemiologia (Basel, Switzerland), 5, 557 - 580
At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods.
Mesinovic M. et al, (2024), Scientific reports, 14
Which trial do we need? A pragmatic randomized trial of trimethoprim-sulfamethoxazole vs. vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia in low-resource settings.
Recht J. et al, (2024), Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Investigation of Escherichia coli isolates from pigs and humans for colistin resistance in Lao PDR- a cross-sectional study
Phomsisavath V. et al, (2024), One Health, 18, 100745 - 100745
Case Report: A case of disseminated cutaneous listeriosis following appendicitis from Lao PDR
Evans TJ. et al, (2024), Wellcome Open Research, 8, 504 - 504
Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms
Citarella BW. et al, (2024), Heliyon, 10, e29591 - e29591